These inhibitory effects would disrupt the cancer cells’ metabolism (by reducing GLUT1) and their invasion and migratory abilities (by reducing MMP7, CXCR4, LOXL2, CXCL12, and vimentin). The gene discussed is CXCL12; the disease is cancer.